RxDoctor Payments Data

Heather Schultz

Family · Amanda, OHNPI 1891982641

Payments from drug & device makers

$1,505in general payments, 2019–2025

Across 92 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$293
  • AstraZeneca$254
  • Abbott$129
  • AbbVie$113
  • Lilly USA, LLC$88
  • Pfizer$84
  • plus $544 from 14 others

What the payments were for

  • Food & beverage$1,46097%
  • Education$453%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,505 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$47,928
Medicare patients
125
Services billed
813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide100$106,871
EliquisApixaban83$59,482
JardianceEmpagliflozin55$52,757
JanuviaSitagliptin Phosphate28$28,812
FarxigaDapagliflozin Propanediol35$23,955
TrulicityDulaglutide19$22,299
XareltoRivaroxaban26$15,405
MounjaroTirzepatide14$15,000
Lantus SolostarInsulin Glargine,hum.Rec.Anlog73$7,964
Breo ElliptaFluticasone/Vilanterol11$4,404
Atorvastatin Calcium306$3,812
Omeprazole187$2,945
Novolog FlexpenInsulin Aspart16$2,059
Celecoxib29$1,848
Pantoprazole Sodium114$1,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$293$106,871100 claims
PfizerEliquis$84$59,48283 claims
Boehringer IngelheimJardiance$27$52,75755 claims
Lilly USA, LLCTrulicity, Mounjaro$88$37,29833 claims
MerckJanuvia$19$28,81228 claims
AstraZenecaFarxiga$254$23,95535 claims
GSKBreo Ellipta$28$4,40411 claims
AbbVieSynthroid$113$1,24825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Amanda

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →